GlassScriptPhysician profile
Gerard J Werries
NPI 1710906649
$3,438.13
in general payments reported to CMS, 2019-2025
21 companies · $780 in 2025
The $780 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,172 · 2020: $593 · 2021: $201 · 2022: $209 · 2023: $153 · 2024: $330 · 2025: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,262.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $762.53 | 2021-2025 | Inceptiv, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Biofire Diagnostics, LLC | $425.00 | 2020 | |
| Stryker Corporation | $302.52 | 2019-2025 | Augment Injectable, Tritanium |
| Cerapedics INC. | $300.22 | 2019-2024 | I-Factor Peptide Enhanced Bone Graft |
| Medtronic USA, INC. | $255.40 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $229.39 | 2019 | |
| Zimmer Biomet Holdings, INC. | $212.06 | 2019 | |
| Lifenet Health | $178.69 | 2025 | Allograft Vmis Delivery System, Pliafx Flo |
| Depuy Synthes Sales INC. | $136.31 | 2019-2020 | |
| Si-Bone, INC. | $131.98 | 2019 | |
| Bioventus LLC | $99.46 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Innovation Technologies INC | $85.76 | 2022 | |
| Endo Pharmaceuticals INC. | $73.15 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $53.16 | 2019-2025 | Euflexxa |
| Becton, Dickinson and Company | $48.73 | 2025 | Channel Drain |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $38.53 | 2025 | |
| Zimvie INC. | $31.55 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $26.45 | 2023 | Iovera, Exparel, Zilretta |
| Pacira Therapeutics, INC. | $19.28 | 2020 | |
| Davol INC. | $17.06 | 2019 | |
| Kerecis Limited | $10.90 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerard Werries listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.